. There was a 2% fall in overall renal transplant numbers in 2014, with a significant fall in kidney donation from donors after circulatory death (10%). . In 2014, death-censored renal transplant failure rates in prevalent patients were similar to previous years at 2.4% per annum. Transplant patient death rates remained stable at 2.3 per 100 patient years. . The median age of incident and prevalent renal transplant patients in the UK was 50.6 and 53.3 years respectively.
. The median eGFR of prevalent renal transplant recipients was 52. 
Introduction
This chapter includes independent analyses regarding renal transplant activity and survival data from the UK Transplant Registry, held by the Organ Donation and Transplantation Directorate (ODT) of NHS Blood and Transplant (NHSBT). The UK Renal Registry (UKRR) has performed additional analyses of renal transplant recipient follow-up data examining demographics, clinical and biochemical variables. NHSBT records all the information regarding the episode of transplantation (donor and recipient details) and the UKRR holds additional information on key clinical and biochemical variables in renal transplant recipients. The co-operation between these two organisations results in a comprehensive database describing the clinical care delivered to renal transplant patients within the UK. This further allows for the comparison of key outcomes between centres and provides insight into the processes involved in the care of such patients in the UK.
This chapter is divided into six sections: (1) transplant activity, waiting list and survival data; (2) transplant demographics; (3) clinical and laboratory outcomes; (4) analysis of prevalent patients by chronic kidney disease (CKD) stage; (5) eGFR slope analysis; and (6) cause of death in transplant recipients. Methodology, results and conclusions of these analyses are discussed in detail for all six sections separately. The UKRR methodology is described elsewhere [1] . The UKRR collects quarterly clinical data via an electronic data extraction process from hospital based renal IT systems on all patients receiving renal replacement therapy. Throughout the chapter, the number preceding the centre name in each figure indicates the percentage of missing data for that centre for that variable.
Unless otherwise specified, prevalent transplant patients were defined as patients with a functioning renal transplant on the 31st December 2014.
A list of the recommended audit measures from the Renal Association which are relevant to the transplant population are given in appendix 1 of this chapter. Several of the audit measures are not currently reported by the UKRR in the annual report; the reasons behind this are varied, but predominantly relate to a high proportion of incomplete data or that the relevant variable is not currently within the specified UKRR dataset. Over time it is hoped to work with the renal community to improve reporting across the range of recommended standards.
Transplant activity, waiting list activity and survival data Introduction NHSBT prospectively collects donor and recipient data around the episode of transplantation. They also request that transplant centres provide an annual paper based data return on the status of the recipient's graft function. This enables ODT to generate comprehensive analyses of renal transplant activity and graft survival statistics.
NHSBT attributes a patient to the centre that performed the transplant operation irrespective of where the patient was cared for before or after the procedure and hence only reports on transplant centre performance.
Methods
In 2014, there were 23 UK adult renal transplant centres, 19 in England, two in Scotland and one each in Northern Ireland and Wales.
Comprehensive information from 1999 onwards concerning the number of patients on the transplant waiting list, the number of transplants performed, the number of deceased kidney donors (donor after brainstem death and donor after circulatory death), living kidney donors, patient survival and graft survival is available on the NHSBT website (http://www.organdonation.nhs.uk/ukt/ statistics/statistics.asp).
Results
During 2014, 3,200 kidney or kidney plus other organ transplants were performed. The absolute number of living kidney donors showed little change in 2014 representing 34.3% of all transplants performed whilst donor after brainstem death transplants continued to increase and comprised 37.7% of all kidney transplants performed. A 10% fall in the number of transplants from donors after circulatory death was also noted in 2014 (table 3.1) .
There were small differences in one and five year riskadjusted patient and graft survival rates amongst UK renal transplant centres (table 3.2). These graft survival rates include grafts with primary non-function (which are excluded from analysis by some countries).
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Conclusions
In 2014, there was a 2% fall in overall renal transplant numbers, with a significant fall in kidney donation from donors after circulatory death (10%). The graft failure rate of 2.4% per annum and patient death rate of 2.3 per 100 patient years were similar to those noted in 2013.
Transplant demographics

Introduction
Since 2008, all UK renal centres have established electronic linkage to the UKRR or Scottish Renal Registry, giving the UKRR complete coverage of individual patient level data across the UK.
The following sections need to be interpreted in the context of variable repatriation policies; some transplant centres continue to follow up and report on all patients they transplant, whereas others refer patients back to non-transplant centres for most or all ongoing posttransplant care. Some transplant centres only refer back patients when their graft is failing. The time posttransplantation that a patient is referred back to their local centre varies between transplant centres. The UKRR is able to detect duplicate patients (being reported from both transplant and referring centres) and in such situations care is usually attributed to the referring centre (see appendix B2 for allocation procedure). This process may result in some discrepancies in transplant numbers particularly in Oxford/Reading and Clywd/Liverpool Royal.
Methods
As Colchester did not have any transplant patients they were excluded from some of the analyses, though their dialysis patients were included in the relevant dialysis population denominators.
For the analysis of primary renal diagnosis (PRD) in transplant recipients, a few centres were excluded from some of the take-on years because of concerns relating to the reliability of PRD coding (with these centres submitting a high percentage of uncertain or missing aetiology codes).
Information on patient demographics (age, gender, ethnicity and PRD) for patients in a given renal centre was obtained from UKRR patient registration data fields. Individual patients were assigned to the centre that returned data for them during 2014. The prevalence of transplant patients in areas covered by individual Clinical Commissioning Groups (CCG) or Health Board/ Social Care Areas (HB) was estimated based on the postcode of the registered address for patients on renal replacement therapy (RRT). Data on ethnic origin, supplied as Patient Administration System (PAS) codes, were retrieved from fields within renal centre IT systems. For the purpose of this analysis, patients were grouped into Whites, South Asians, Blacks, Others and Unknown. The details of ethnicity regrouping into the above categories are provided in appendix H: Coding https://www.renalreg.org/ publications-reports/.
Results and Conclusions
Prevalent transplant numbers across the UK are described in table 3.3.
The prevalence of renal transplant recipients in each CCG/HB in England, Northern Ireland (Health and Social Care Trust Areas), Scotland (Health Boards) and Wales (Local Health Boards) and the proportion of prevalent patients according to modality in the renal centres across the UK is described in tables 3.4 and 3.5 respectively. After standardisation for age and gender, unexplained variability was evident in the prevalence of renal transplant recipients, with some areas having higher than the predicted number of prevalent transplant patients per million population and others lower. There are a number of potential explanations for these inconsistencies, including Pruthi/Casula/MacPhee Pruthi/Casula/MacPhee Pruthi/Casula/MacPhee geographical differences in access to renal transplantation in the UK. This has previously been analysed in detail by the UKRR [2] and is currently the focus of a large national study (access to Transplant and Transplant Outcome Measures (ATTOM)).
The proportion of prevalent RRT patients with a transplant relative to the number on dialysis has gradually risen over the last decade.
Age and gender
The gender ratio amongst incident and prevalent transplant patients has remained stable for at least the last ten years (table 3.6, figure 3.1). Note, absolute patient numbers differ from those published in previous reports as a result of additional data validation and reallocation of patients. The average age of incident transplant patients has steadily increased during the same time period. There has also been a gradual increase in the average age of prevalent transplant patients, which could reflect the increasing age at which patients are transplanted and/or improved survival after renal transplantation over the last few years. The prevalent transplant patient workload across the UK increased to 31,164 patients at the end of 2014. The continued expansion of this patient group means there is a need for careful planning by renal centres for future service provision and resource allocation.
Primary renal diagnosis
The primary renal diagnosis of patients receiving kidney transplants in the UK has remained relatively stable over the last five years (table 3.7).
Ethnicity
It was difficult to compare the proportion of patients within each ethnic group receiving a transplant to those commencing dialysis from the same group because data on ethnicity were missing in a considerable number of patients who were classified as ethnicity 'unknown' (table 3.8). The percentages of patients with unknown ethnicity between 2009 and 2013 provided in this year's chapter are different from those in last year's chapter [3] ; this reflects retrospective input of ethnicity data, improving data completeness. Introduction There continued to be marked variation in the completeness of data (tables 3.9a, 3.9b) reported by each renal centre, particularly for blood pressure. Better data records (or possibly better extraction of data held within renal IT systems) would facilitate more meaningful comparisons between centres and help to determine the causes of inter-centre differences in outcomes. For this reason, along with differences in repatriation policies of prevalent transplant patients between centres as highlighted previously, caution needs to be exercised when comparing centre performance.
The 71 renal centres in the UK comprise 52 centres in England, five in Wales, five in Northern Ireland and nine in Scotland. Colchester was reported as having no transplanted patients and was therefore excluded. After exclusion of this centre, prevalent patient data from 70 renal centres across the UK were analysed.
For the one year post-transplant analyses, in which patients were assigned to the centre that performed their transplant, all 23 transplant centres across the UK were included in the analysis.
Methods
Data for key laboratory variables are reported for all prevalent patients with valid data returns for a given renal centre (both transplanting and non-transplanting centres) and for one year post-transplant results for patients transplanted 2007-2013, with patients attributed to the transplant centre that performed the procedure.
Time since transplantation may have a significant effect on key biochemical and clinical variables and this is likely to be independent of a centre's clinical practices. Therefore, inter-centre comparison of data on prevalent transplant patients is open to bias. To minimise bias relating to fluctuations in biochemical and clinical parameters occurring in the initial post-transplant period, one year post-transplantation outcomes are also reported. It is presumed that patient selection policies and local clinical practices are more likely to be relevant in influencing outcomes 12 months post-transplant and therefore comparison of outcomes between centres is more robust. However, even the 12 months post-transplant comparisons could be biased by the fact that in some centres, repatriation of patients only occurs if the graft is failing whereas in others it only occurs if the graft function is stable.
Centres with ,20 patients or ,50% data completeness have been excluded from the figures. Scottish centres were also excluded from blood pressure analyses as data were not provided.
Prevalent patient data
Biochemical and clinical data for patients with a functioning transplant followed in either a transplanting or non-transplanting centre were included in the analyses. The cohort consisted of prevalent patients as on 31st December 2014. Patients were considered as having a functioning transplant if 'transplant' was listed as the last mode of RRT in the last quarter of 2014. Patients were assigned to the renal centre that sent the data to the UKRR but some patients will have received care in more than one centre. If data for the same transplant patient were received from both the transplant centre and non-transplant centre, care was usually allocated to the non-transplant centre (see appendix B2). Patients with a functioning transplant of less than three months duration were excluded from analyses. For haemoglobin, estimated glomerular filtration rate (eGFR), corrected calcium, phosphate and blood pressure (BP), the latest value in quarter 3 or quarter 4 of 2014 was used.
Estimated glomerular filtration rate (eGFR)
For the purpose of eGFR calculation, the original 4-variable MDRD formula was used (with a constant of 186) to calculate 861  89  71  86  86  62  M RI  1,163  96  72  96  96  52  Middlbr  492  91  39  90  90  10  Newc  627  99  92  99  99  65  Norwch  328  97  98  95  95  21  Nottm  598  98  82  96  93  92  Oxford  1,057  98  71  98  98  39  Plymth  317  96  62  93  93  38  Ports  876  95  59  92  90  22  Prestn  522  99  66  98  97  62  Redng  382  99  81  99  87  51  Salford  436  96  89  96  95  56  Sheff  695  99  63  99  99  26  Shrew  123  89  75  82  82  2  Stevng  263  98  60  94  83  47  Sthend  101  98  54  97  94  16  Stoke  349  99  99  99  98  59  Sund  217  97  95  97  97  92  Truro  207  100  99  99  99  92  Wirral  14  86  93  86  86  71  Wolve  182  96  82  95  85  66  York  278  94  59  93  90  13 Outcomes in UK renal transplant recipients in 2014 One year post-transplant data Patients who received a renal transplant between 1st January 2007 and 31st December 2013 were assigned according to the renal centre in which they were transplanted. In a small number of instances, the first documented evidence of transplantation in a patient's record is from a timeline entry in data returned from a non-transplant centre, in these instances the patient was reassigned to the nearest transplant centre.
Patients who had died or experienced graft failure within 12 months of transplantation were excluded from the analyses.
Patients with more than one transplant during 2007-2013 were included as separate episodes provided each of the transplants functioned for a year.
For each patient, the most recent laboratory or blood pressure result for the relevant 4th/5th quarter after renal transplantation was taken to be representative of the one year post-transplant outcome. Again, for the purpose of the eGFR calculation patients with valid serum creatinine results but missing ethnicity data were classed as White.
Results and conclusions
Post-transplant eGFR in prevalent transplant patients
When interpreting eGFR post-transplantation, it is important to remember that estimated GFR formulae only have a modest predictive performance in the transplant population [4] . Median eGFR in each centre and percentage of patients with eGFR ,30 ml/min/1.73 m Table 3 .10 summarises the proportion of transplant patients with an eGFR ,30 ml/min/1.73 m 2 by centre. Whilst local repatriation policies on timing of transfer of care for patients with failing transplants from transplant centres to referring centres might explain some of the differences, it is notable that both transplanting and non-transplanting centres feature at both ends of the scale. The accuracy of the 4-variable MDRD equation in estimating GFR 5 60 ml/min/1.73 m 2 is questionable [5] , therefore a figure describing this is not included in this chapter. Graft function at one year post-transplantation may predict subsequent long term graft outcome [6] . Figures 3.5a, 3 .5b, and 3.5c show the median one year post-transplant eGFR for patients transplanted between 2007-2013, by transplant type. Living kidney donation had the highest median eGFR at one year (57.4 ml/min/ 1.73 m 2 ), followed by donation after brainstem death (53.6 ml/min/1.73 m 2 ) and donation after circulatory death (50.1 ml/min/1.73 m 2 ). Figures 3.6a, 3.6b and 3 .6c show one year post-transplant eGFR by donor type and year of transplantation. An upward trend in eGFR (p = 0.0007) over the time period was noticed with live kidney donation transplantation, but not with donation after brainstem death (p = 0.14) or donation after circulatory death (p = 0.4).
Haemoglobin in prevalent transplant patients
Transplant patients have previously fallen under the remit of the UK Renal Association Complications of Chronic Kidney Disease (CKD) guidelines. Updated guidelines regarding the management of anaemia in CKD were published by the association in November 2010 [7] which have now been adopted for this report. These guidelines recommend 'achieving a population distribution centred on a mean of 11 g/dl with a range of 10-12 g/dl' [8] (equivalent to 110 g/L, range 100-120 g/L). However, many transplant patients with good transplant function will have haemoglobin concentrations .120 g/L without the use of erythopoiesis stimulating agents, and so it is inappropriate to audit performance using the higher limit.
A number of factors including comorbidity, immunosuppressive medication, graft function, ACE inhibitor use, erythropoietin (EPO) use, intravenous or oral iron use, as well as centre practices and protocols for management of anaemia, affect haemoglobin concentrations in transplant patients. Most of these data are not collected by the UKRR and therefore caution must be used when interpreting analyses of haemoglobin attainment. predicted proportion of transplant patients not achieving the haemoglobin target. Six centres fell outside the lower 99.9% CI, indicating they performed better than expected with fewer than predicted patients having a haemoglobin ,100 g/L.
Blood pressure in prevalent transplant patients
In the absence of controlled trial data, the opinion based recommendation of the UK Renal Association (RA) published in the 2010 guideline for the care of kidney transplant recipients is that 'Blood pressure should be <130/80 mmHg (or <125/75 mmHg if proteinuria)' [9] . This blood pressure target is the same as that used in previous annual reports [10] .
As indicated in table 3.9a, completeness for blood pressure data returns was variable and only centres with .50% data returns were included for consideration. Despite this restriction, caution needs to be exercised in interpretation of these results because of the volume of missing data and potential bias, (e.g. a centre may be more likely to record and report blood pressure data electronically in patients with poor BP control). Figures 3.10a and 3.10b show 
Introduction
Approximately 2.4% of prevalent transplant patients returned to dialysis in 2014, a similar percentage to that seen over the last few years. Amongst patients with native chronic kidney disease, late presentation is associated with poor outcomes, largely attributable to lack of specialist management of anaemia, acidosis, hyperphosphataemia and to inadequate advance preparation for dialysis. Transplant recipients on the other hand, are almost always followed up regularly in specialist transplant or renal clinics and it would be reasonable to expect patients with failing grafts to receive appropriate care and therefore have many of their modifiable risk factors addressed before complete graft failure and return to dialysis.
Methods
The transplant cohort consisted of prevalent transplant recipients as on 31st December 2014 (N = 28,707) and were classified according to the KDIGO staging criteria with the suffix of 'T' to represent their transplant status. Patients with missing ethnicity information were classified as White for the purpose of calculating eGFR. Prevalent dialysis patients, except those who commenced dialysis in 2014, comprised the comparison dialysis cohort (N = 21,408) including 2,222 peritoneal dialysis patients. Only patients on peritoneal dialysis were considered when examining differences in serum phosphate between transplant recipients and dialysis patients. For both the transplant and dialysis cohorts, the analysis used the most recent available value from the last two quarters of the 2014 laboratory data. Scottish centres were excluded from blood pressure, cholesterol and PTH analyses as corresponding data were not provided. Table 3 .11 shows that 13% of the prevalent transplant population (3,732 patients), had moderate to advanced Introduction Differences in causes of death between dialysis and transplant patients may be expected due to selection for transplantation and use of immunosuppression. Chapter 5 includes a more detailed discussion on cause of death in dialysis patients.
Results and conclusions
Methods
The cause of death is sent by renal centres as an ERA-EDTA registry code. These have been grouped into the following categories: cardiac disease, cerebrovascular disease, infection, malignancy, treatment withdrawal, other and uncertain.
Some centres have high data returns to the UKRR regarding cause of death, whilst others return no information. Provision of this information is not mandatory. Analysis of prevalent patients included all those aged over 18 years and receiving RRT on 1st January 2014. Table 3 .13 and figure 3 .11 show the differences in the cause of death between prevalent dialysis and transplant patients. Table 3 .14 shows the cause of death for prevalent transplant patients by age. Death due to cardiovascular disease was less common in transplanted patients than in dialysis patients, perhaps reflecting the shows blood pressure management remained suboptimal). Explanations for the rising death rate secondary to malignancy may include the increasing age of transplant recipients and the increased intensity of immunosuppressive regimens leading to complications of over-immunosuppression.
Results and conclusions
